SB 1068
Modifies provisions relating to pharmacies and pharmacists
Sponsor:
LR Number:
4717S.06T
Last Action:
7/10/2008 - Signed by Governor
Journal Page:
Title:
CCS SB 1068
Calendar Position:
Effective Date:
August 28, 2008
House Handler:

Current Bill Summary

CCS/SB 1068 - This act modifies provisions relating to pharmacies and pharmacists.

PHARMACY REBATES FUND

This act establishes the Pharmacy Rebates Fund for the purposes of depositing any revenues received by the state from pharmaceutical manufacturer rebates as required by state or federal law for use in the MO HealthNet pharmacy program. SECTION 338.650

This provision is substantially similar to HB 2193 (2008).

AUDITS

This act establishes procedures for when certain prescribed entities conduct audits of pharmacies. Each entity conducting an audit shall establish an appeals process, lasting no longer than six months, under which a licensed pharmacy may appeal an unfavorable preliminary audit report. The audit procedures established under this act shall not apply to any audit conducted as part of an investigation that involves probable fraud, willful misrepresentation, or abuse, nor shall such procedures apply to any audit conducted as part of an inspection or investigation conducted by any governmental entity or law enforcement agency. SECTION 338.600

This provision is substantially similar to SCS/HCS/HB 1332 (2008).

FIBROMYALGIA AWARENESS PROGRAM

This act establishes within the Department of Health and Senior Services the "Missouri Fibromyalgia Awareness Initiative Program." The primary target population for such program shall be women between twenty and sixty years of age.

The department shall appoint and convene a Missouri Fibromyalgia Panel, which shall be empowered to raise at least fifty thousand dollars through private funding for the purpose of establishing a public information and outreach campaign, working with other state and local agencies to promote education and training programs for physicians and other health care professionals, and examining the pharmaceutical treatments available for such patients.

This program shall be implemented only to the extent that the panel obtains private funding for the program. SECTION 338.410

This provision is substantially similar to a provision in HB 2243 (2008).

ADRIANE CROUSE

Amendments